Patient and Family Information

  • We place an emphasis on education that is directed toward patients and the public as well as future allergy-immunology caregivers.

    Patient-Oriented Education

    Sufferers of moderate to severe asthma can provide countless stories of trips to emergency rooms. Management of asthma has historically been to provide an intervention to someone having a respiratory attack. The physicians at UTMB are changing this paradigm.

    In addition to providing information related to how to take current medications and what to do in the event of an attack, the physicians at UTMB are teaching their patients how to monitor and manage their respiratory health to prevent them from ever having to make a trip to the emergency room.

    Community Physician Education

    Faculty within UTMB's Allergy, Immunology and Otolaryngology departments volunteer to travel to community hospitals located throughout Southeast Texas to provide an opportunity to discuss findings and treatments related to respiratory disorders.

    Topics discussed include:

    • Allergic Rhinitis
    • State of the Art Management of Asthma
    • Update on Research in Allergy
    • Allergic Rhinitis/Sinusitis in Children
    • Asthma in Children
    • Pediatric Pulmonary Diseases (other than Asthma)
    • Management of Allergies in Children
    • Anaphylaxis Community Experts


    UTMB Multispecialty Center, League City

    Mondays (Flex day, pending physician availability)1 – 4 pm
    Tuesdays & Wednesdays8 – 11 am
    1 – 4 pm
    Thursdays8 – 11 am
    Fridays1 – 4 pm

    UTMB Health Clinics, Galveston

    Mondays8:30 – 10:30 am
    Wednesdays1:30 – 3:30 pm

    Please schedule your appointments in advance – these clinics fill up quickly. As a patient safety measure, we ask that you allow 30 minutes for observation after your injection is given.

  • Research is a central focus of UTMB’s Division of Allergy and Immunology. Since the creation of the division in the early 1970s, it has been one of the region's premier research-oriented allergy centers. Our research focuses on advancing the understanding of allergic and immunologic disorders, as well as improving measures for diagnosis and treatment. Clinical trials are carried out under strict guidelines with great attention to participant safety.

    Individuals choose to participate in clinical research for many reasons. Some like the idea of being able to receive treatment with promising therapies before they are approved by the Food and Drug Administration for widespread commercial use. Others have tried conventional treatments and are in search of a new option. Still others may participate in clinical research in efforts to advance science and medicine.

    We currently are conducting studies on hereditary angioedema, ACE inhibitor-induced angioedema, asthma, and immunodeficiencies. New studies are added frequently; call to check with us about our latest research and trials.

    Available Resources

    UTMB Health is home to several unique facilities and programs that support clinical research and provide world class clinical and research opportunities.

    Clinical Research Center

    Child Health Research Center

    Research Pharmacy

    Aerospace Medicine Program

    Affiliation with Shriners Burns Hospital

    WHO Collaborating Center for Tropical Diseases

    Institute for Translational Sciences
    The ITS is the academic home of a five-year, $21.5 million Clinical Translational Sciences Award (CTSA) by the National Institutes of Health– National Center for Research Resources. The National CTSA Consortium, which currently includes 46 institutions, is working to improve human health by transforming the research and training environment to enhance the efficiency and quality of clinical and translational research.

    NIH NHLBI Proteomics Center
    UTMB is one of seven institutions which are part of a new proteomics program launched by the NHLBI on August 15, 2010. Collectively, the participating centers were awarded $83.5 million. UTMB has been a part of the NHLBI Proteomics Initiative since 2002. The new network consists of Boston University, Johns Hopkins University, Massachusetts General Hospital, Stanford University, the University of California-Los Angeles, the University of Texas Health Sciences Center at San Antonio, and UTMB Health.

    Some of the pioneering concepts and research activities undertaken by our team include:

    • Identification of CC chemokines as IgE-independent histamine-releasing factors
    • The use of CpG for treatment for Th2 inflammation and asthma
    • Identification of pollen NADPH oxidase as a critical player in allergic airway inflammation
    • Identification of mitochondrial proteins and their role in allergic inflammation
    • Bronchscopy & BAL studies in patients with allergic asthma subjects for biomarkers
    • Examination of relationship between food allergy and respiratory allergy
    • Defining the role of xenoestrogens in asthma and other allergic disorders

    We currently are conducting studies on hereditary angioedema, asthma, and immunodeficiencies. New studies are added frequently; call to check with us about our latest research and trials.

    For more information about research studies and clinical trials, please contact us.



Meet the Team

Our Locations